![]() |
Name |
Caryophyllene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene
|
|
SMILES |
C/C/1=C\CCC(=C)[C@H]2CC([C@@H]2CC1)(C)C
|
|
InChI |
InChI=1S/C15H24/c1-11-6-5-7-12(2)13-10-15(3,4)14(13)9-8-11/h6,13-14H,2,5,7-10H2,1,3-4H3/b11-6+/t13-,14-/m1/s1
|
|
InChIKey |
NPNUFJAVOOONJE-GFUGXAQUSA-N
|
|
Synonyms |
BETA-CARYOPHYLLENE; Caryophyllene; trans-Caryophyllene; (-)-trans-Caryophyllene; 87-44-5; L-Caryophyllene; (-)-beta-caryophyllene; (-)-(E)-Caryophyllene; .beta.-Caryophyllene; b-caryophyllene; trans-beta-caryophyllene; (E)-Caryophyllene; (E)-beta-caryophyllene; Beta-Caryophylene; trans-.beta.-Caryophyllene; (-)-Caryophyllene; .beta.-Caryophyllen; FEMA No. 2252; CHEBI:10357; (E)-beta-caryophylene; .beta.-(E)-Caryophyllene; beta-Caryophyllen; NSC-11906; (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene; g-Caryophyllene; 8-Methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene; NSC 11906; (1R,4E,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene; Bicyclo(7.2.0)undec-4-ene, 8-methylene-4,11,11-trimethyl-, (E)-(1R,9S)-(-)-; E-.beta.-caryophyllene; BHW853AU9H; .beta.-Caryophyllene, (-); Tincturoid; 8-Methylene-4,11,11-(trimethyl)bicyclo[7.2.0]undec-4-ene; NSC11906; Caryophyllene B; beta-cariofillene; (1R,4E,9S)-4,11,11-trimethyl-8-methylene-bicyclo[7.2.0]undec-4-ene; beta-caryophillene; (1R,4E,9S)-4,11,11-TRIMETHYL-8-METHYLENEBICYCLO(7.2.0)UNDEC-4-ENE; Bicyclo[7.2.0]undec-4-ene, 8-methylene-4,11,11-trimethyl-, (E)-(1R,9S)-(-)-; Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R-(1R*,4E,9S*)]-; E-beta-caryophyllene; MFCD00075925; Caryophyllene, (E); (?)-b-caryophyllene; beta-(e)-caryophyllene; beta-trans-caryophyllene; (?)-trans-Caryophyllene; DSSTox_CID_4739; CARYOPHYLLENE [MI]; .beta.-trans-Caryophyllene; (-)-I(2)-caryophyllene; DSSTox_RID_77517; DSSTox_GSID_24739; CHEMBL445740; BETA-CARYOPHYLLENE [FCC]; DTXSID8024739; BETA-CARYOPHYLLENE [INCI]; Bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1R,4E,9S)-; HY-N1415; ZINC8234282; .BETA.-CARYOPHYLLENE [FHFI]; Tox21_301497; (1S,9R)-6,10,10-trimethyl-2-methylenebicyclo[7.2.0]undec-5-ene; BDBM50529607; s6058; AKOS024283988; LMPR0103120001; beta-Caryophyllene, >=80%, FCC, FG; CAS-87-44-5; NCGC00142620-01; NCGC00255159-01; (-)-trans-Caryophyllene, analytical standard; CS-0016839; C09629; beta-Caryophyllene 2000 microg/mL in Acetonitrile; Q421614; W-109317; (-)-trans-Caryophyllene, >=98.5% (sum of enantiomers, GC); trans-(1R,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene; 8-Methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene, (1R,4E,9S)-; Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, (E)-(1R,9S)-(-)-; Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R- (1R*,4E,9S*)]-
|
|
CAS | 87-44-5 | |
PubChem CID | 5281515 | |
ChEMBL ID | CHEMBL445740 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.478 |
Caco-2 Permeability: | -4.611 | MDCK Permeability: | 0.00002260 |
Pgp-inhibitor: | 0.095 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.765 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.557 | Plasma Protein Binding (PPB): | 92.17% |
Volume Distribution (VD): | 2.514 | Fu: | 9.21% |
CYP1A2-inhibitor: | 0.566 | CYP1A2-substrate: | 0.583 |
CYP2C19-inhibitor: | 0.4 | CYP2C19-substrate: | 0.829 |
CYP2C9-inhibitor: | 0.379 | CYP2C9-substrate: | 0.879 |
CYP2D6-inhibitor: | 0.078 | CYP2D6-substrate: | 0.766 |
CYP3A4-inhibitor: | 0.161 | CYP3A4-substrate: | 0.254 |
Clearance (CL): | 5.458 | Half-life (T1/2): | 0.1 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.157 |
Drug-inuced Liver Injury (DILI): | 0.131 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.03 | Maximum Recommended Daily Dose: | 0.834 |
Skin Sensitization: | 0.606 | Carcinogencity: | 0.065 |
Eye Corrosion: | 0.661 | Eye Irritation: | 0.886 |
Respiratory Toxicity: | 0.307 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001826 | ![]() |
1.000 | D0L2LS | ![]() |
0.262 | ||
ENC001663 | ![]() |
0.673 | D0D2VS | ![]() |
0.259 | ||
ENC002199 | ![]() |
0.519 | D0K0EK | ![]() |
0.250 | ||
ENC002652 | ![]() |
0.519 | D06CGB | ![]() |
0.247 | ||
ENC001469 | ![]() |
0.491 | D0A2AJ | ![]() |
0.247 | ||
ENC001297 | ![]() |
0.446 | D0Z1XD | ![]() |
0.244 | ||
ENC002990 | ![]() |
0.414 | D0F2AK | ![]() |
0.241 | ||
ENC001316 | ![]() |
0.414 | D0C7JF | ![]() |
0.241 | ||
ENC000800 | ![]() |
0.390 | D00ZFP | ![]() |
0.241 | ||
ENC001279 | ![]() |
0.373 | D04ATM | ![]() |
0.236 |